Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-21-017527

Chief Scientific Officer sold 9,518 shares at an average $38.70 ($368,329)

From the SEC's structured data for this filing

Trades in this filing

Leen Ann M. · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-01 Sale : show line 1 in the form −6,359 $38.46 $244,572 2,465,326 I
2021-03-01 Sale : show line 2 in the form −3,159 $39.18 $123,758 2,462,167 I
Open-market sales · 9,518 sh · avg $38.70 · $368,329
Loading xslF345X03/doc4.xml…